Beacon Capital Management LLC (Tennessee)’s Quest Diagnostics DGX Stock Holding History

Beacon Capital Management LLC (Tennessee)’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-65	Closed	-$11.6K	–	336
2025 Q2	$11.6K	Buy	65 +1	+2%	+$174	﹤0.01%	606
2025 Q1	$10.9K	Hold	64	–	–	﹤0.01%	609
2024 Q4	$9.65K	Buy	64 +29	+83%	+$4.51K	﹤0.01%	607
2024 Q3	$5.43K	Buy	+35	New	+$5.23K	﹤0.01%	794
2024 Q1	–	Sell	-9	Closed	-$1.1K	–	1089
2023 Q4	$1.1K	Hold	9	–	–	﹤0.01%	861
2023 Q3	$1.26K	Hold	9	–	–	﹤0.01%	896
2023 Q2	$1.26K	Hold	9	–	–	﹤0.01%	896
2023 Q1	$1.27K	Hold	9	–	–	﹤0.01%	813
2022 Q4	$1.41K	Hold	9	–	–	﹤0.01%	843
2022 Q3	$1K	Hold	9	–	–	﹤0.01%	790
2022 Q2	$1K	Hold	9	–	–	﹤0.01%	845
2022 Q1	$1K	Buy	+9	New	+$1.25K	﹤0.01%	845

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Beacon Capital Management LLC (Tennessee)'s DGX Position: Q3 2025 in Review

Beacon Capital Management LLC (Tennessee) sold out of Quest Diagnostics (DGX) in Q3 2025, closing a stake of 65 shares — an estimated $11.6K sold.

Beacon Capital Management LLC (Tennessee) first reported a position in DGX in Q1 2022 and held it in 12 quarters. The position peaked at $11.6K in Q2 2025. 1,008 funds tracked by Wall St. Rank hold DGX as of Q3 2025.

Beacon Capital Management LLC (Tennessee) reported no remaining Quest Diagnostics position as of Q3 2025 after selling out during the quarter.
Beacon Capital Management LLC (Tennessee) sold 65 Quest Diagnostics shares in Q3 2025, an estimated $11.6K.
Beacon Capital Management LLC (Tennessee) first reported a position in Quest Diagnostics in Q1 2022 and held it in 12 quarters.
Beacon Capital Management LLC (Tennessee)'s Quest Diagnostics position peaked at $11.6K in Q2 2025.
1,008 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2025.

Based on Beacon Capital Management LLC (Tennessee)'s 13F filing for Q3 2025, filed 7 Nov 2025.